Skip to content
Unrated Drug recall · FDA · Published September 20, 2022

QuVa Pharma Oxytocin IV Solution Recall: Incorrect Sodium Chloride Concentration

QuVa Pharma recalls oxyTOCIN 30 Units/500mL IV solution due to incorrect sodium chloride concentration (0.45% instead of 0.9%). This compounded product for institutional use may cause complications if administered improperly.

🇺🇸 FDA recall #D-1544-2022DrugQuVa Pharma ›
Take action

Contact the company

Recalling firmQuVa Pharma, Inc.519 State Route 173 · Bloomsbury, NJ 08804-4047
✎ GovInfoNow plain-language explainer

QuVa Pharma has recalled oxyTOCIN 30 Units/500 mL IV solutions that were compounded with 0.45% Sodium Chloride instead of the required 0.9% Sodium Chloride. This error could lead to improper medical treatment if used in IV administration. Read more at govinfonow.com/recall/34319-quva-pharma-oxytocin-iv-solution-recall-incorrect-sodium-chloride-concentration.

Source Summary by GovInfoNow · govinfonow.com/recall/34319-quva-pharma-oxytocin-iv-solution-recall-incorrect-sodium-chloride-concentration · Updated August 18, 2026 · FDA enforcement record: FDA #D-1544-2022

Cite this page

“QuVa Pharma Oxytocin IV Solution Recall: Incorrect Sodium Chloride Concentration.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34319-quva-pharma-oxytocin-iv-solution-recall-incorrect-sodium-chloride-concentration. Based on FDA recall #D-1544-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1544-2022%22&limit=1).

The FDA announced on September 20, 2022, that QuVa Pharma, Inc. recalled oxyTOCIN due to incorrect product formulation. The hazard involves the drug being added to 0.45% Sodium Chloride instead of the labeled 0.9% Sodium Chloride.

How to tell if you have it

  • Brand: QuVa Pharma
  • Product: oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to Sodium Chloride, Injection for IV Use
  • NDC: 70092-1068-07
  • Lot: 30027403
  • BUD: 11/14/2022
  • Quantity: 1994 bags

The hazard

The recall addresses the incorrect product formulation where Oxytocin 30 units was added to an IV bag of 0.45% Sodium Chloride (500mL) rather than the specified 0.9% Sodium Chloride (500mL).

Context

GovInfoNow's records show QuVa Pharma, Inc. has 9 other recalls on record since March 30, 2016. Other recent recalls of similar products include QuVa Pharma Recalls Methohexital Sodium Due to Impurity Failures (June 24, 2026), QuVa Pharma Recalls R.E.C.K. Injection Due to Particulate Matter (October 10, 2025), and QuVa Pharma Fentanyl Citrate Bupivacaine Solution Recall: Lack of Sterility Assurance (March 6, 2025).

How to tell if you have this one

Look for the product name 'oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride, Injection for IV Use'. Check the lot number 30027403 with a batch date of 11/14/2022.

  • Brand
    QuVa Pharma
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the lot number and batch date on the product label to confirm if it matches lot 30027403 with a batch date of 11/14/2022.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 5 months after the firm started it.

1. Firm started the recall: Sep 20, 202212. FDA classified it Class III: Sep 26, 202223. Published in FDA’s Enforcement Report: Oct 5, 202234. FDA terminated the recall: Feb 8, 2023420222023
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this product available for resale?

The product is described as 'Not for Resale' for institutional or office use only.

Similar recalls

Other QuVa Pharma recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1544-2022 (September 20, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1544-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA